Investing

The global data, analytics and AI company will use the Series J funds to invest in new AI products, complete acquisitions and expand its international go-to-market operations.

AI will transform healthcare with advances in multimodal technology, diagnostic imaging and automation, but its success depends on trust and seamless integration into workflows.

Some executives anticipate an acceleration of M&A activity as struggling startups seek exits, while others foresee more funding opportunities for companies with proven value in the sector.

Leaders weigh in on the digital health funding environment, women's health investments and how "AI washing" may influence capital raises.

The company touts that it recently surpassed 2.5 million rings sold and has seen its member base and revenue more than double over the past year.

John Saran, a partner at Holland & Knight, says now that the election is over and uncertainty has been addressed, healthcare clients are generally optimistic and are anticipating a return to normal when it comes to deal making in 2025.

The Series A investment brings the company's total capital raise to $20 million.

Josh Di Frances, vice president and head of incubation at LG NOVA, highlights the winners of the company’s 2024 Startup Pitch Competition held annually at LG NOVA’s annual InnoFest, which included mDETECT, Glidance and Oncoustics.

The funding brings the company's Series C funding round to a close and total capital raised to $155 million.

The company will use the funds to accelerate the development of its Ellipse Spinal Cord Stimulator Platform, used to treat chronic pain.